Karsten Geletneky

This inventor holds 12 USPTO granted patents and 3 published patent applications, plus 8 CIPO patents and 10 EPO patents. Top assignees: Deutsches Krebsforschungszentrum, Ruprecht-Karls-Universitaet Heidelberg, Ruprecht-Karls-Universitat Heidelberg. Active years: 2005-2022.

USPTO Granted Patents = 12 (Patent Applications = 3)

% Patents Active = 91.7

CIPO Patents = 8

EPO Patents = 10 (Patent Applications = 14)

Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 25(Granted Patents)

Company Filing History:

8 out of 159

Deutsches Krebsforschungszentrum

patents

5 out of 23

Ruprecht-Karls-Universitaet Heidelberg

patents

4 out of 64

Ruprecht-Karls-Universitat Heidelberg

patents

4. 2 out of 20

Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts

patents

5. 2 out of 166

Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts

patents

6. 1 out of 2

Ruprecht-Karis-Universität Heidelberg

patents

where one patent can have more than one assignee

Years Active: 2005-2022

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11324788 - Parvovirus formulation for treating tumors (2022-05-10),

2. 10813959 - Cancer therapy with a parvovirus combined with bevacizumab (2020-10-27),

3. 10624935 - Parvovirus formulation for treating tumors (2020-04-21),

4. 10525091 - Use of parvovirus for eliminating cancer stem cells (CSCs) (2020-01-07),

5. 10406185 - Cancer therapy with a parvovirus combined with a BCL-2 inhibitor (2019-09-10),

6. 9889169 - Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor (2018-02-13),

7. 9861669 - Oncolytic virotherapy for prevention of tumor recurrence (2018-01-09),

8. 9700588 - Use of parvovirus for eliminating cancer stem cells (CSCs) (2017-07-11),

9. 9446099 - Method for brain cancer therapy by co-administration of a parvovirus and interferon-gamma (2016-09-20),

10. 8414883 - Parvovirus cancer therapy and combination with chemotherapy (2013-04-09),

11. 7179456 - Use of parvovirus for brain tumor therapy (2007-02-20),

12. 6927281 - Adeno-associated virus-its diagnostic use with early abortion (2005-08-09),

Title: Karsten Geletneky - Innovative Inventor from Heidelberg

Introduction: Karsten Geletneky is a renowned inventor hailing from Heidelberg, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Karsten Geletneky holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With over two decades of experience in the industry, Karsten Geletneky has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized various sectors.

Collaborations: Throughout his career, Karsten Geletneky has collaborated with top universities and multinational corporations to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Karsten Geletneky's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in Heidelberg and beyond.